Who is TOPOGEN
TopoGEN is a research diagnostics company that provides innovative products and services for researchers working with topoisomerases and engaged in mechanism based drug discovery and deve...
Read More
- Headquarters: Buena Vista, Colorado, 81211, United States
- Date Founded: 1991
- Employees: 1-10
- Revenue: $1 Million to $5 Million
- Active Tech Stack: See technologies
- CEO: Mark Muller
Industry: Biotechnology
SIC Code: 2835 | NAICS Code: 621511 | Show More
TopoGEN Org Chart and Mapping
Similar Companies to TopoGEN
Edgewise Therapeutics
- 51-200
- $ 25 Million to 50 Million
Enveda Biosciences
- 51-200
- $ 1 Million to 5 Million
Lifeline Cell Technology
- 11-50
- $ 25 Million to 50 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding TopoGEN
Answer: TopoGEN's headquarters are located at Buena Vista, Colorado, 81211, United States
Answer: TopoGEN's official website is https://topogen.com
Answer: TopoGEN's revenue is $1 Million to $5 Million
Answer: TopoGEN's SIC: 2835
Answer: TopoGEN's NAICS: 621511
Answer: TopoGEN has 1-10 employees
Answer: TopoGEN is in Biotechnology
Answer: TopoGEN top competitors include: Edgewise Therapeutics , Enveda Biosciences , Lifeline Cell Technology
Answer: TopoGEN contact info: Phone number: Website: https://topogen.com
Answer: TopoGEN is a research diagnostics company that provides innovative products and services for researchers working with topoisomerases and engaged in mechanism based drug discovery and development. The company was created by topo research active scientists who understand the needs and the restraints placed on other cancer researchers or those working in areas peripheral to topoisomerases. Top-selling products include: -Drug Screening Kits to identify topoisomerase active drugs for use in cancer chemotherapy and antibacterial applications -Assay Kits for assaying prokaryotic and eukaryotic topoisomerases (type I, II, IV, gyrase), both in vitro and in vivo -A complete line of DNA substrates and DNA cleavage targets, topoisomerase inhibitors, topoisomerase antibodies, and kit replenishment reagents Our contract screening service offers you powerful, mechanism based custom screens developed and conducted entirely in house. Our cell based (in vivo) screens for detecting topoisomerase I and II poisons in the context of the cancer cell represents the new gold standard for identification of novel anti cancer agents. Since the early 1990s TopoGEN has maintained a dedicated clientele around the world. We offer substantial product support, data interpretation and consultation advice. When you become our customer, we become your partner in research. We review your data and offer valuable input. Please contact us for further information about how we can assist your research goals.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month